Bicycle Therapeutics (BCYC) Other Gross PP&E Adjustments (2018 - 2026)

Bicycle Therapeutics posted quarterly Other Gross PP&E Adjustments of $15.0 million for Q1 2026, down 20.7% year-on-year from $18.9 million in Q1 2025, and up 21.36% on a QoQ basis from $12.3 million in Q4 2025.

Bicycle Therapeutics (BCYC) has 9 years of Other Gross PP&E Adjustments data on file, last reported at $15.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 20.7% year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (down 20.7% YoY), and the FY2025 full-year result was $12.3 million, up 5179.84% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at $15.0 million, up from $12.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $24.1 million in Q3 2025 and bottomed at -$4.0 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $11.1 million (2023), against an average of $10.7 million.
  • The widest annual swing landed in 2022, when Other Gross PP&E Adjustments tumbled 455.08%; it then jumped 5179.84% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.2 million in 2022, then slumped by 171.44% to -$838000.0 in 2023, then surged by 71.0% to -$243000.0 in 2024, then surged by 5179.84% to $12.3 million in 2025, then gained by 21.36% to $15.0 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at $15.0 million (Q1 2026), $12.3 million (Q4 2025), and $24.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -60,691.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -892,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -189.30 Mn
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn - 14.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.98 Mn
Mar 31, 2026 14.98 Mn
Dec 31, 2025 12.34 Mn
Dec 31, 2025 12.34 Mn
Sep 30, 2025 24.14 Mn
Sep 30, 2025 24.14 Mn
Jun 30, 2025 23.27 Mn
Jun 30, 2025 23.27 Mn
Mar 31, 2025 18.89 Mn
Mar 31, 2025 18.89 Mn
Dec 31, 2024 -243,000.00
Dec 31, 2024 -243,000.00
Sep 30, 2024 20.42 Mn
Sep 30, 2024 20.42 Mn
Jun 30, 2024 15.82 Mn
Jun 30, 2024 15.82 Mn
Mar 31, 2024 14.21 Mn
Mar 31, 2024 14.21 Mn
Dec 31, 2023 -838,000.00
Dec 31, 2023 -838,000.00
Sep 30, 2023 11.08 Mn
Sep 30, 2023 11.08 Mn
Jun 30, 2023 9.68 Mn
Jun 30, 2023 9.68 Mn
Mar 31, 2023 6.86 Mn
Mar 31, 2023 6.86 Mn
Dec 31, 2022 1.17 Mn
Dec 31, 2022 1.17 Mn
Sep 30, 2022 7.70 Mn
Sep 30, 2022 7.70 Mn
Jun 30, 2022 6.07 Mn
Jun 30, 2022 6.07 Mn
Mar 31, 2022 -3.98 Mn
Mar 31, 2022 -3.98 Mn
Dec 31, 2021 -11.15 Mn
Dec 31, 2021 -11.15 Mn
Sep 30, 2021 1.85 Mn
Sep 30, 2021 1.85 Mn
Jun 30, 2021 1.44 Mn
Jun 30, 2021 1.44 Mn
Mar 31, 2021 1.12 Mn
Mar 31, 2021 1.12 Mn
Dec 31, 2020 3.30 Mn
Dec 31, 2020 3.30 Mn
Sep 30, 2020 2.35 Mn
Sep 30, 2020 2.35 Mn
Jun 30, 2020 2.14 Mn
Jun 30, 2020 2.14 Mn
Mar 31, 2020 2.49 Mn
Mar 31, 2020 2.49 Mn
Dec 31, 2019 2.05 Mn
Dec 31, 2019 2.05 Mn
Sep 30, 2019 1.01 Mn
Sep 30, 2019 1.01 Mn
Jun 30, 2019 1.23 Mn
Jun 30, 2019 1.23 Mn
Dec 31, 2018 2.26 Mn
Dec 31, 2018 2.26 Mn